Intuitive Surgical ISRG · USD
Health Care · Health Care Equipment & Supplies · US listing · 🇺🇸 United States
S&P 500Nasdaq-100
460.56
+1.71%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Intuitive Surgical
From its filings with the US Securities and Exchange Commission
Intuitive Surgical is based in Sunnyvale, California and is incorporated in Delaware. Its shares trade on Nasdaq under the ticker ISRG. It is a member of the S&P 500 and Nasdaq-100. The SEC classifies its business as orthopedic, prosthetic & surgical appliances & supplies. In the fiscal year to 31 December 2025, it reported revenue of $10.06bn and net income of $2.86bn. At that date it held total assets of $20.46bn and shareholders' equity of $17.82bn.
As part of Intuitive’s mission, we believe that minimally invasive care is life-enhancing care. By combining ingenuity and intelligent technology, we expand the potential of physicians to heal without constraints. We envision a future of care that is less invasive and profoundly better, where diseases are identified early and treated quickly so patients can get back to what matters most.
Since our founding over 30 years ago, we have been delivering on this mission and vision by combining innovative technology with clinical expertise to advance minimally invasive care. We do so by providing a comprehensive ecosystem that includes robotic-assisted systems, instruments and accessories, customer learning, and customer support services all connected by a digital portfolio that enables actionable insights across the care continuum. Among other capabilities, these products and services can augment the skills and improve the efficiency of clinicians and care teams while providing decision support and learning that can help deliver differentiated clinical and economic value for patients, providers, and payers when compared to the next best available treatment options.
Quoted from its 10-K, filed 3 Feb 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 1 Jun 2006
- Employees
- 17,021
- Website
- intuitivesurgical.com ↗
- Head office
- 1020 KIFER ROAD, SUNNYVALE, CA, 94086
- Incorporated in
- DE
- Classification
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- Filer status
- Large accelerated filer
Leadership
Pay as last reported
- Dr. Gary GuthartExecutive Chairman of the Board, since 2002$18.2m
- Mr. David RosaChief Executive Officer, Director, since 2011$13.8m
- Mr. Jamie SamathExecutive Vice President, Chief Financial Officer, Head of Business Technology$7.0m
- Mr. Bob DeSantisExecutive Vice President, Chief Strategy and Corporate Operations Officer$4.8m
- Mr. Henry CharltonExecutive Vice President, Chief Commercial and Marketing Officer$6.5m
- Mr. Gary LoebExecutive Vice President, Chief Legal and Compliance Officer
- Dr. Myriam CuretExecutive Vice President, Chief Medical Officer$4.5m
- Mr. Brian MillerExecutive Vice President, Chief Digital Officer$6.2m
- Mr. Mark BrosiusSenior Vice President, Chief Manufacturing and Supply Chain Officer
- Dr. Craig BarrattLead Independent Director$466,664
- Mr. Joseph BeeryIndependent Director$354,903
- Mr. Lewis ChewIndependent Director$339,069
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 63
- Environment
- 53
- Social
- 86
- Governance
- 51
- Direct emissions (scope 1)
- 8,105 t
- Energy emissions (scope 2)
- 25,382 t
- Value chain emissions (scope 3)
- 558,786 t
- Women in the workforce
- 38.6%
- Carbon reduction policy
- No
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Intuitive Surgical Inc benefits from being a market leader in the development and manufacturing of robotic surgical systems. Its flagship product, the da Vinci Surgical System, has set the standard for advanced minimally invasive surgery, providing superior precision and control to surgeons.
- The company offers a diverse range of robotic surgical systems and related instruments, enabling it to cater to various medical specialties. This comprehensive product portfolio enhances Intuitive Surgical's competitive advantage and allows it to address the needs of different surgeons and hospitals effectively.
- Intuitive Surgical has built a loyal and expanding customer base, comprising hospitals, surgical centers, and healthcare professionals worldwide. The company's innovative technology and proven track record have instilled trust and confidence in its customers, leading to continued strong demand for its products.
Weaknesses
- The da Vinci Surgical System and its associated instruments come with a significant price tag, making them expensive investments for hospitals and healthcare institutions. Additionally, the ongoing maintenance costs can pose financial challenges for customers, potentially limiting the company's market penetration in cost-sensitive regions or facilities.
- While Intuitive Surgical's technology is widely used across various surgical fields, the majority of its revenue still relies heavily on specific procedures such as prostatectomy and hysterectomy. This concentration exposes the company to risks associated with changes in medical practices, reimbursement policies, or competing technologies.
Opportunities
- Intuitive Surgical can explore untapped opportunities in emerging markets, where robotic-assisted surgery adoption is still in its early stages. By expanding its presence and offering flexible pricing options tailored to the local market dynamics, the company can capitalize on the growing demand for advanced surgical technologies.
- The field of robotic surgery is rapidly evolving, presenting Intuitive Surgical with opportunities to further enhance its product offerings and maintain its technological leadership. By investing in research and development, the company can introduce innovative features, improve surgical outcomes, and expand into new surgical applications.
Threats
- Intuitive Surgical faces intense competition from both established medical device companies and emerging players in the robotic surgical market. Competitors may develop comparable or superior technologies, potentially eroding the market share and pricing power of Intuitive Surgical's products.
- The regulatory environment and reimbursement policies surrounding robotic surgery can pose challenges for Intuitive Surgical. Changes in regulations, reimbursement rates, or insurance coverage may impact the adoption and financial viability of its products, affecting the company's revenue and competitive position.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.